Caris Life Sciences

IPO

Where Molecular Science Meets Artificial Intelligence

Public · Irving, United States · Founded 2008 · $1.5B raised

Headquarters
Irving, Texas
Employees
1001–5000
Founded
2008
Business Model
B2B2C
Total Funding
$1.5B
Last Round
$168.0M Growth EquityApr 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Caris Life Sciences is a next-generation AI TechBio company and precision medicine pioneer delivering comprehensive molecular profiling of cancer at the DNA, RNA, and protein level. The company has built one of the world's largest multimodal databases with 740,000+ matched molecular and clinical outcomes records, applying AI and machine learning to classify cancer and predict patient response. Its products — MI Profile, MI Cancer Seek, Caris Assure, and AI signatures — support physicians, patients, and biopharma partners across the full care continuum.

Summary

Caris Life Sciences is a Diagnostics company based in Irving, United States, founded in 2008. It has raised $1.5B in total across 4 rounds, most recently a $168.0M Growth Equity round in Apr 2025. Investors include OrbiMed, Sixth Street and Braidwell LP.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityApr 2025
$168.0M

Sign up to see all 5 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Agendia

Molecular diagnostics company focused solely on breast cancer, developing and commercializing per...

Irvine, United StatesBiotech, Diagnostics
Growth EquityTotal funding$123.0MJul 2018
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Venture RoundTotal funding$470.0MDec 2024
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series CTotal funding$435.0MJun 2021
BillionToOneIPO

BillionToOne develops single-molecule diagnostic tests that improve prenatal screening and help c...

Menlo Park, United States201–500Biotech, Diagnostics
Venture RoundTotal funding$406.0MMar 2026
NateraIPO

Natera develops cell-free DNA tests that help clinicians guide care in oncology, women’s health, ...

San Carlos, United States5001–10000Diagnostics, Genomics
Series ETotal funding$310.1MJul 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Caris Life Sciences on Indexed.vc
<a href="https://indexed.vc/companies/caris-life-sciences"><img src="https://indexed.vc/api/badge/company/caris-life-sciences" alt="Caris Life Sciences on Indexed.vc" width="260" height="76" /></a>